RxDoctor Payments Data

Dinh Pham, MD

Geriatric Medicine · Parkland, FLNPI 1861495657

Payments from drug & device makers

$250in general payments, 2019–2025

Across 9 payments — averaging $27.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$125
  • Pfizer$77
  • Astellas Pharma US Inc$33
  • Lilly USA, LLC$15

What the payments were for

  • Food & beverage$250100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$250 in reported general payments places this provider in the 45th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$617,249
Medicare patients
577
Services billed
6,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban381$204,602
XareltoRivaroxaban117$67,829
MyrbetriqMirabegron114$57,080
JanuviaSitagliptin Phosphate67$33,169
OzempicSemaglutide26$31,770
EntrestoSacubitril/Valsartan47$29,233
TrulicityDulaglutide22$21,988
LinzessLinaclotide29$17,161
FarxigaDapagliflozin Propanediol31$16,057
Memantine Hcl268$13,985
JardianceEmpagliflozin15$13,058
CreonLipase/Protease/Amylase16$12,324
TradjentaLinagliptin18$12,268
Atorvastatin Calcium710$11,783
Levothyroxine Sodium827$11,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$77$204,602381 claims
Astellas Pharma US IncMyrbetriq$33$57,080114 claims
Lilly USA, LLCTrulicity$15$21,98822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Parkland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →